John C. Byrd, MD, director of the division of hematology at The Ohio State University Comprehensive Cancer Center, discusses the role of Bruton's Tyrosine Kinase (BTK) in chronic lymphocytic leukemia (CLL).
For more ASH 2012 coverage: [ Ссылка ]
Ещё видео!